Philadelphia, PA, 12 October, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology and co-owned by the American Society for Investigative Pathology, publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. Articles include studies in oncology, infectious disease, inherited disease or predisposition to disease, as well as technical advances in molecular diagnosis, and application of diagnostic methodologies in clinical trials. Editor-in-Chief, Timothy J. O'Leary (Washington, DC), along with the JMD's Associate Editors, Editorial Board, and contributing authors represent many of the recognized authorities in the field.
"Elsevier is thrilled to partner with AMP and ASIP to publish the JMD. The journal is at the forefront in publishing translational research and technological advances in molecular medicine. We welcome the journal and the societies into the Elsevier family," states Andrew Berin, Publishing Director, Elsevier.
Dr. Mark E. Sobel, Executive Officer of both the Association for Molecular Pathology and the American Society for Investigative Pathology, states, "AMP and ASIP are confident that partnering with Elsevier will enable us to further our goal of globally promoting clinical applications and research in molecular pathology by expanding the reach and impact of the high-quality articles published in The Journal of Molecular Diagnostics."
About The Association for Molecular Pathology
The Association for Molecular Pathology (AMP) is an international medical professional association dedicated to the advancement, practice, and science of clinical molecular laboratory medicine and translational research based on the applications of molecular biology, genetics and genomics. Through the efforts of an enthusiastic membership from across the United States and around the world, AMP continues to grow in numbers and influence. The organization is divided into the scientific subdivisions of genetics, infectious diseases, hematopathology, and solid tumors. The AMP membership includes individuals from academic medical centers, independent laboratories, government, and industry, including physicians, laboratory directors, scientists, medical technologists, and trainees. AMP members are at the forefront of the development and implementation of novel molecular diagnostic tests, whether these are laboratory developed or commercially developed. AMP members proudly accept their responsibilities in assessing the analytical validity, clinical validity, clinical utility, and the clinical utilization of molecular tests for each specific patient. For more information, please visit: www.amp.org.
About The American Society for Investigative Pathology
The American Society for Investigative Pathology (ASIP) is an educational professional not-for-profit society dedicated to the discovery, advancement, and dissemination of basic and translational knowledge in experimental pathology and related disciplines. This is achieved by fostering investigation into the pathogenesis, classification, diagnosis, and manifestations of disease through meetings, publications, and educational activities. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms, using a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP advocates for the practice of investigative pathology and fosters the professional career development and education of its members. For more information, please visit: www.asip.org.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Journal of Molecular Diagnostics